Patents by Inventor Barbara DYMEK

Barbara DYMEK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • YKL-40 inhibitors and their therapeutic
    Patent number: 12325701
    Abstract: Disclosed are assays for screening active compounds interfering with interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as interfering with interaction between chitinase-like protein YKL-40 and heparan sulfate. Moreover, disclosed are active compounds identified by these assays as inhibitors of chitinase-like protein YKL-40, their therapeutic applications, and their use in biosensors measuring the level of chitinase-like protein YKL-40 in biological samples.
    Type: Grant
    Filed: March 3, 2023
    Date of Patent: June 10, 2025
    Assignee: Molecure S.A.
    Inventors: Łukasz Krzemiński, Wojciech Czestkowski, Marzena Mazur, Gleb Andryianau, Sylwia Olejniczak, Michal Czesław Piotrowicz, Robert Koralewski, Elżbieta Pluta, Krzysztof Matyszewski, Michał Kowaiski, Barbara Dymek, Rafał Kozieł, Jacek Olozak, Adam Gołębiowski, Agnieszka Bartoszewicz, Katarzyna Krysztofiak
  • YKL-40 INHIBITORS AND THEIR THERAPEUTIC APPLICATIONS
    Publication number: 20230278996
    Abstract: Disclosed are novel assays for screening active compounds interfering with interaction between chitinase-like protein YKL-40 and chitin oligomers, as well as interfering with interaction between chitinase-like protein YKL-40 and heparan sulfate. Moreover, disclosed are novel active compounds identified by these assays as inhibitors of chitinase-like protein YKL-40, their therapeutic applications, and their use in biosensors measuring the level of chitinase-like protein YKL-40 in biological samples.
    Type: Application
    Filed: March 3, 2023
    Publication date: September 7, 2023
    Inventors: Lukasz Krzeminski, Wojciech Czestkowski, Marzena Mazur, Gleb Andryianau, Sylwia Olejniczak, Michal Czeslaw Piotrowicz, Robert Koralewski, Elzbieta Pluta, Krzysztof Matyszewski, Michal Kowalski, Barbara Dymek, Rafal Koziel, Jacek Olczak, Adam Golebiowski, Agnieszka Bartoszewicz, Katarzyna Krysztofiak
  • 7-(morpholin-4-yl)pyrazole[1,5-A]pyrimidine derivatives as PI3 kinase inhibitors
    Patent number: 10138247
    Abstract: A compound of the general formula (I) wherein Y represents —CH2— or >C=0; R1 is selected from the group consisting of A1, A2 and A3; R2 represents dioxothiomorpholino moiety B1, piperazinyl moiety B2, azetidinyl moiety B3, or piperidinyl moiety B4; R3 is selected from the group consisting of H, halogen, and C1-C4 alkyl; R4 is selected from the group consisting of C1-C4 alkyl, C3-C4-cycloalkyl, C1-C4 alkyl substituted with C1-C4 alkoxy, and CHF2, and their pharmaceutically acceptable salts. Pharmaceutical compositions comprising said compounds and their use in the treatment of diseases of immune system, inflammatory diseases and cancer.
    Type: Grant
    Filed: March 30, 2016
    Date of Patent: November 27, 2018
    Assignee: CELON PHARMA, S.A.
    Inventors: Barbara Dymek, Marcin Zagozda, Maciej Wieczorek, Krzysztof Dubiel, Aleksandra Stanczak, Daria Zdzalik, Pawel Gunerka, Mariola Sekular, Maciej Dziachan
  • 7-(MORPHOLIN-4-YL)PYRAZOLE[1,5-A]PYRIMIDINE DERIVATIVES WHICH ARE USEFUL FOR THE TREATMENT OF IMMUNE OR INFALMMATORY DISEASES OR CANCER
    Publication number: 20180111939
    Abstract: A compound of the general formula (I) wherein Y represents —CH2— or >C=0; R1 is selected from the group consisting of A1, A2 and A3; R2 represents dioxothiomorpholino moiety B1, piperazinyl moiety B2, azetidinyl moiety B3, or piperidinyl moiety B4; R3 is selected from the group consisting of H, halogen, and C1-C4 alkyl; R4 is selected from the group consisting of C1-C4 alkyl, C3-C4-cycloalkyl, C1-C4 alkyl substituted with C1-C4 alkoxy, and CHF2, and their pharmaceutically acceptable salts. Pharmaceutical compositions comprising said compounds and their use in the treatment of diseases of immune system, inflammatory diseases and cancer.
    Type: Application
    Filed: March 30, 2016
    Publication date: April 26, 2018
    Inventors: Barbara DYMEK, Marcin ZAGOZDA, Maciej WIECZOREK, Krzysztof DUBIEL, Aleksandra STANCZAK, Daria ZDZALIK, Pawel GUNERKA, Mariola SEKULAR, Maciej DZIACHAN